Easy Access and Express Report Delivery Service
Cell Therapy and Gene Therapy CDMO Market, Global Outlook and Forecast 2023-2029
Report ID
46057
Publisher
Market Monitor Global
Published Date
22-Dec
Delivery Format
PDF
No of Report Page
107
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Cell Therapy and Gene Therapy CDMO market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cell Therapy and Gene Therapy CDMO market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cell Therapy and Gene Therapy CDMO, challenges faced by the industry, and potential opportunities for market players. The global Cell Therapy and Gene Therapy CDMO market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cell Therapy and Gene Therapy CDMO market presents opportunities for various stakeholders, including Clinical Stage Projects, Commercialization Stage Projects. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cell Therapy and Gene Therapy CDMO market. Additionally, the growing consumer demand present avenues for market expansion. The global Cell Therapy and Gene Therapy CDMO market was valued at US$ 2942.7 million in 2022 and is projected to reach US$ 11040 million by 2029, at a CAGR of 21.1% during the forecast period. Key Features: The research report on the Cell Therapy and Gene Therapy CDMO market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cell Therapy and Gene Therapy CDMO market. Market Overview: The report provides a comprehensive overview of the Cell Therapy and Gene Therapy CDMO market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cell Therapy, Gene Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cell Therapy and Gene Therapy CDMO market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cell Therapy and Gene Therapy CDMO market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cell Therapy and Gene Therapy CDMO market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Cell Therapy and Gene Therapy CDMO market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Cell Therapy and Gene Therapy CDMO market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cell Therapy and Gene Therapy CDMO market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cell Therapy and Gene Therapy CDMO, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cell Therapy and Gene Therapy CDMO market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Cell Therapy and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type Cell Therapy Gene Therapy Market segment by Application Clinical Stage Projects Commercialization Stage Projects Global Cell Therapy and Gene Therapy CDMO Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Lonza Pharmaceuticals Thermo Fisher catalent Jubilant LifeSciences Boehringer Ingelheim Oxford BioMedica Charles River WuXi AppTec He Yuan Biology GenScript Biotech Kanglong Chemical Porton shares Sano Biologics Yunzhou Biology Outline of Major Chapters: Chapter 1: Introduces the definition of Cell Therapy and Gene Therapy CDMO, market overview. Chapter 2: Global Cell Therapy and Gene Therapy CDMO market size in revenue. Chapter 3: Detailed analysis of Cell Therapy and Gene Therapy CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Cell Therapy and Gene Therapy CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Cell Therapy and Gene Therapy CDMO Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Cell Therapy and Gene Therapy CDMO Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Cell Therapy and Gene Therapy CDMO Overall Market Size 2.1 Global Cell Therapy and Gene Therapy CDMO Market Size: 2022 VS 2029 2.2 Global Cell Therapy and Gene Therapy CDMO Market Size, Prospects & Forecasts: 2018-2029 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Cell Therapy and Gene Therapy CDMO Players in Global Market 3.2 Top Global Cell Therapy and Gene Therapy CDMO Companies Ranked by Revenue 3.3 Global Cell Therapy and Gene Therapy CDMO Revenue by Companies 3.4 Top 3 and Top 5 Cell Therapy and Gene Therapy CDMO Companies in Global Market, by Revenue in 2022 3.5 Global Companies Cell Therapy and Gene Therapy CDMO Product Type 3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy and Gene Therapy CDMO Players in Global Market 3.6.1 List of Global Tier 1 Cell Therapy and Gene Therapy CDMO Companies 3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy and Gene Therapy CDMO Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Cell Therapy and Gene Therapy CDMO Market Size Markets, 2022 & 2029 4.1.2 Cell Therapy 4.1.3 Gene Therapy 4.2 By Type - Global Cell Therapy and Gene Therapy CDMO Revenue & Forecasts 4.2.1 By Type - Global Cell Therapy and Gene Therapy CDMO Revenue, 2018-2023 4.2.2 By Type - Global Cell Therapy and Gene Therapy CDMO Revenue, 2024-2029 4.2.3 By Type - Global Cell Therapy and Gene Therapy CDMO Revenue Market Share, 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Cell Therapy and Gene Therapy CDMO Market Size, 2022 & 2029 5.1.2 Clinical Stage Projects 5.1.3 Commercialization Stage Projects 5.2 By Application - Global Cell Therapy and Gene Therapy CDMO Revenue & Forecasts 5.2.1 By Application - Global Cell Therapy and Gene Therapy CDMO Revenue, 2018-2023 5.2.2 By Application - Global Cell Therapy and Gene Therapy CDMO Revenue, 2024-2029 5.2.3 By Application - Global Cell Therapy and Gene Therapy CDMO Revenue Market Share, 2018-2029 6 Sights by Region 6.1 By Region - Global Cell Therapy and Gene Therapy CDMO Market Size, 2022 & 2029 6.2 By Region - Global Cell Therapy and Gene Therapy CDMO Revenue & Forecasts 6.2.1 By Region - Global Cell Therapy and Gene Therapy CDMO Revenue, 2018-2023 6.2.2 By Region - Global Cell Therapy and Gene Therapy CDMO Revenue, 2024-2029 6.2.3 By Region - Global Cell Therapy and Gene Therapy CDMO Revenue Market Share, 2018-2029 6.3 North America 6.3.1 By Country - North America Cell Therapy and Gene Therapy CDMO Revenue, 2018-2029 6.3.2 US Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.3.3 Canada Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.3.4 Mexico Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4 Europe 6.4.1 By Country - Europe Cell Therapy and Gene Therapy CDMO Revenue, 2018-2029 6.4.2 Germany Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4.3 France Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4.4 U.K. Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4.5 Italy Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4.6 Russia Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4.7 Nordic Countries Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.4.8 Benelux Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.5 Asia 6.5.1 By Region - Asia Cell Therapy and Gene Therapy CDMO Revenue, 2018-2029 6.5.2 China Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.5.3 Japan Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.5.4 South Korea Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.5.5 Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.5.6 India Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.6 South America 6.6.1 By Country - South America Cell Therapy and Gene Therapy CDMO Revenue, 2018-2029 6.6.2 Brazil Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.6.3 Argentina Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Cell Therapy and Gene Therapy CDMO Revenue, 2018-2029 6.7.2 Turkey Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.7.3 Israel Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.7.4 Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 6.7.5 UAE Cell Therapy and Gene Therapy CDMO Market Size, 2018-2029 7 Cell Therapy and Gene Therapy CDMO Companies Profiles 7.1 Lonza Pharmaceuticals 7.1.1 Lonza Pharmaceuticals Company Summary 7.1.2 Lonza Pharmaceuticals Business Overview 7.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.1.4 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.1.5 Lonza Pharmaceuticals Key News & Latest Developments 7.2 Thermo Fisher 7.2.1 Thermo Fisher Company Summary 7.2.2 Thermo Fisher Business Overview 7.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.2.4 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.2.5 Thermo Fisher Key News & Latest Developments 7.3 catalent 7.3.1 catalent Company Summary 7.3.2 catalent Business Overview 7.3.3 catalent Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.3.4 catalent Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.3.5 catalent Key News & Latest Developments 7.4 Jubilant LifeSciences 7.4.1 Jubilant LifeSciences Company Summary 7.4.2 Jubilant LifeSciences Business Overview 7.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.4.4 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.4.5 Jubilant LifeSciences Key News & Latest Developments 7.5 Boehringer Ingelheim 7.5.1 Boehringer Ingelheim Company Summary 7.5.2 Boehringer Ingelheim Business Overview 7.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.5.4 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.5.5 Boehringer Ingelheim Key News & Latest Developments 7.6 Oxford BioMedica 7.6.1 Oxford BioMedica Company Summary 7.6.2 Oxford BioMedica Business Overview 7.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.6.4 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.6.5 Oxford BioMedica Key News & Latest Developments 7.7 Charles River 7.7.1 Charles River Company Summary 7.7.2 Charles River Business Overview 7.7.3 Charles River Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.7.4 Charles River Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.7.5 Charles River Key News & Latest Developments 7.8 WuXi AppTec 7.8.1 WuXi AppTec Company Summary 7.8.2 WuXi AppTec Business Overview 7.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.8.4 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.8.5 WuXi AppTec Key News & Latest Developments 7.9 He Yuan Biology 7.9.1 He Yuan Biology Company Summary 7.9.2 He Yuan Biology Business Overview 7.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.9.4 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.9.5 He Yuan Biology Key News & Latest Developments 7.10 GenScript Biotech 7.10.1 GenScript Biotech Company Summary 7.10.2 GenScript Biotech Business Overview 7.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.10.4 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.10.5 GenScript Biotech Key News & Latest Developments 7.11 Kanglong Chemical 7.11.1 Kanglong Chemical Company Summary 7.11.2 Kanglong Chemical Business Overview 7.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.11.4 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.11.5 Kanglong Chemical Key News & Latest Developments 7.12 Porton shares 7.12.1 Porton shares Company Summary 7.12.2 Porton shares Business Overview 7.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.12.4 Porton shares Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.12.5 Porton shares Key News & Latest Developments 7.13 Sano Biologics 7.13.1 Sano Biologics Company Summary 7.13.2 Sano Biologics Business Overview 7.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.13.4 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.13.5 Sano Biologics Key News & Latest Developments 7.14 Yunzhou Biology 7.14.1 Yunzhou Biology Company Summary 7.14.2 Yunzhou Biology Business Overview 7.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Major Product Offerings 7.14.4 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue in Global Market (2018-2023) 7.14.5 Yunzhou Biology Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
